Press release from Companies: WntResearch lämnar fördjupad information om den planerade fas 2-prövningen med läkemedelskandidaten Foxy-5

Press release from Companies: WntResearch lämnar fördjupad information om den planerade fas 2-prövningen med läkemedelskandidaten Foxy-5

Press release from Companies: WntResearch Provides Further Information on the Planned Phase 2 Trial with the Drug Candidate Foxy-5

Press release from Companies: WntResearch Provides Further Information on the Planned Phase 2 Trial with the Drug Candidate Foxy-5

Press release from Companies: WntResearch Provides Further Information on the Planned Phase 2 Trial with the Drug Candidate Foxy-5

Press release from Companies: Kommuniké från extra bolagsstämma den 20 september 2017 i WntResearch AB

Press release from Companies: Kommuniké från extra bolagsstämma den 20 september 2017 i WntResearch AB

Press release from Companies: Kommuniké från extra bolagsstämma den 20 september 2017 i WntResearch AB

More from the company: WntResearch: Som meddelats 4 september visar ny forskning att Foxy-5 motverkar spridning av prostatacancerceller

More from the company: WntResearch: Som meddelats 4 september visar ny forskning att Foxy-5 motverkar spridning av prostatacancerceller

More from the company: WntResearch: As announced September 4.th new research findings show that Foxy-5 counteracts spread of prostate cancer cells

More from the company: WntResearch: As announced September 4.th new research findings show that Foxy-5 counteracts spread of prostate cancer cells